SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes

Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon

Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...

A new study shows that physical activity can add years to your life. Is this enough to motivate behavior change?

The first of its kind, Why WAIT is a creative app-based approach to weight loss and diabetes management

Regular eye screenings are important for people with diabetes. Learn more about diabetes-related retinopathy screenings from diabetes advocates Renza and Grumpy

The FDA finds that some versions of extended-release metformin contain excessive amounts of a cancer-causing chemical called NDMA

The SGLT-2 inhibitor becomes the first diabetes medicine approved to treat kidney disease and reduce the risk of hospitalization for heart failure in people with type 2...

En el Mes Nacional de la Salud de las Minorías, el autor comparte la historia de su diagnóstico de diabetes tipo 2

Check out the third day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on off label use in type 1 diabetes, type 2 diabetes remission,...

We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use...

Food insecurity affects many people in the US, particularly people with diabetes. Resources exist to help those without access to enough, nutritious food, and Dr. Seth...

Major milestones in 2019 brought time in range to the forefront of diabetes care

For some, school cancelations and working from home have added stress that can make diabetes management even more difficult. Here are the perspectives and strategies of...

People using Novo Nordisk insulin who have lost health insurance coverage due to job loss during COVID-19 are eligible for free insulin for 90 days

In exciting news for digital diabetes prevention programs, a new study showed that highly engaged participants – those who more frequently engaged in food logging,...

As Black Lives Matter protests continue throughout the world, we put together a few tips to help you protest safely while living with diabetes. In addition, read on for...

SNAP and WIC help connect millions of individuals and families to affordable, nutritious foods. Here are how these programs are evolving

At our second virtual Musings Under the Moon gathering, expert panelists discussed emerging needs in diabetes care, including prevention, inequities, partnerships, and...

Dr. Messer and Dr. Riddell give tips on how to use AID devices to manage blood glucose levels while exercising